Get the Stockscreener App
80.93
0.74%
0.45
After Hours:
80.90
-0.03
-0.04%
Transmedics Group Inc stock is traded at $80.93, with a volume of 1.81M.
It is up +0.74% in the last 24 hours and down -35.96% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$80.48
Open:
$78.21
24h Volume:
1.81M
Relative Volume:
1.27
Market Cap:
$2.71B
Revenue:
$401.09M
Net Income/Loss:
$32.64M
P/E Ratio:
-73.57
EPS:
-1.1
Net Cash Flow:
$-120.51M
1W Performance:
-9.02%
1M Performance:
-35.96%
6M Performance:
-41.24%
1Y Performance:
+18.01%
1-Day Range:
$76.21
$81.31
1-Week Range:
$76.21
$98.88
52-Week Range:
$66.76
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| TMDX | 80.93 | 2.71B | 401.09M | 32.64M | -120.51M | -1.10 |
| ABT | 117.38 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.57 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.46 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.66 | 112.92B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.88B | 6.60B | 4.16B | 490.10M | 2.34 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
Navigating 11 Analyst Ratings For TransMedics Gr - Benzinga
TransMedics Group (NASDAQ:TMDX) Shares Gap Down Following Analyst Downgrade - MarketBeat
TransMedics Group (NASDAQ:TMDX) Price Target Lowered to $120.00 at TD Cowen - MarketBeat
Vaughan Nelson Investment Management L.P. Buys 64,360 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group (NASDAQ:TMDX) Shares Down 9%Here's Why - MarketBeat
Short Interest in TransMedics Group, Inc. (NASDAQ:TMDX) Increases By 30.9% - MarketBeat
Objective long/short (TMDX) Report - Stock Traders Daily
Is TransMedics Group Stock a Buy? - AOL
Black Swift Group LLC Sells 9,200 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Baillie Gifford & Co. Decreases Stake in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Amalgamated Bank Purchases 8,660 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics: Overreaction To Temporary Headwinds (Rating Upgrade) (NASDAQ:TMDX) - Seeking Alpha
54,795 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Acquired by WCM Investment Management LLC - MarketBeat
Principal Financial Group Inc. Buys 146,115 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Lisanti Capital Growth LLC Sells 25,775 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Stake Boosted by Montanaro Asset Management Ltd - MarketBeat
New York State Teachers Retirement System Makes New $1.22 Million Investment in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Down 52%, Is TransMedics Stock a Buy on the Dip? - AOL
Down 52%, Is TransMedics Stock A Buy On The Dip? - Barchart
Down 52%, Is TransMedics Stock a Buy on the Dip? - The Motley Fool
Why TransMedics Stock Plunged in October - AOL
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX) - Business Wire
TransMedics director Basile sells shares worth $563,993 By Investing.com - Investing.com Canada
TransMedics director Basile sells shares worth $563,993 - Investing.com India
Transmedics Group Inc (TMDX-Q) QuotePress Release - The Globe and Mail
New York State Common Retirement Fund Decreases Stake in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Why Global Foundries Stock Jumped Today - AOL
(TMDX) Trading Signals - Stock Traders Daily
1 Top Growth Stock Down 50% to Buy After Its Recent Pullback - Yahoo! Voices
Brokerages Set TransMedics Group, Inc. (NASDAQ:TMDX) PT at $144.80 - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Emerald Advisers LLC - MarketBeat
These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results - MSN
TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - The Malaysian Reserve
3 Stocks Well Below 52-Week Highs With Strong Growth Projections - MarketBeat
16,308 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Acquired by State of Alaska Department of Revenue - MarketBeat
William Blair Has Negative Estimate for TMDX FY2024 Earnings - MarketBeat
TMDX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Business Wire
TransMedics Group (NASDAQ:TMDX) Sees Large Volume IncreaseTime to Buy? - MarketBeat
This Is What Whales Are Betting On TransMedics Gr - Benzinga
TransMedics (TMDX) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
What You Can Learn From TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S After Its 44% Share Price Crash - Simply Wall St
TransMedics: Maintaining A Neutral Stance After A Difficult Q3 (NASDAQ:TMDX) - Seeking Alpha
William Blair Predicts Higher Earnings for TransMedics Group - MarketBeat
TransMedics Group Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2024 Earnings Call Transcript - MSN
TransMedics Group Posts Weak Results, Joins Harmonic, Crocs, D.R. Horton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - MSN
TransMedics Group (FRA:8T8) Owner Earnings per Share (TTM) : -2.02 (As of Sep. 2024) - GuruFocus.com
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - WV News
TransMedics: Every Hero Becomes A Bore At Last (NASDAQ:TMDX) - Seeking Alpha
Organ Transplant MedTech TransMedics Q3 Performance Disappoints, Analyst Outlines Investor Worries - Yahoo Finance
TransMedics Group (NASDAQ:TMDX) Earns Overweight Rating from Piper Sandler - MarketBeat
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Transmedics Group Inc Stock (TMDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Khayal Tamer I | Chief Commercial Officer |
Nov 11 '24 |
Sale |
90.04 |
1,458 |
131,278 |
20,843 |
| Basile Edward M | Director |
Nov 05 '24 |
Option Exercise |
28.12 |
6,750 |
189,810 |
7,482 |
| Basile Edward M | Director |
Nov 05 '24 |
Sale |
83.55 |
6,750 |
563,994 |
732 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 01 '24 |
Option Exercise |
13.28 |
1,083 |
14,382 |
21,926 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 01 '24 |
Sale |
82.64 |
1,083 |
89,499 |
20,843 |
1.18%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):